Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.

Citation metadata

Date: July 20, 2021
Publisher: American Medical Association
Document Type: Report
Length: 43 words

Document controls

Main content

Abstract :

Novel therapies that optimize lipid metabolism to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) include PCSK-9 inhibitors, bempedoic acid, icosapent ethyl and inclisiran. These treatments are considered when lifestyle modifications and statin therapy are not enough to achieve adequate ASCVD risk reduction.

Source Citation

Source Citation   

Gale Document Number: GALE|A679726707